mCRPC	Metastatic castration resistant prostate cancer
OS	Overall survival
PD	Progressive disease
NLR	Neutrophil-to-lymphocyte ratio
PFS	Progression-free survival
PSA	Prostate specific antigen
IQR	Interquartile range
ALP	Alkaline phosphatase
LDH	Lactate dehydrogenase
ULN	Upper normal limit
PCWG2	Prostate cancer working group 2
HR	Hazard ratio
95%CI	95% confidence interval
ECOG	Eastern Collaborative Oncology Group Performance Status
CR	Complete remission
PR	Partial remission
SD	Stable disease